| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 20:54 | FBN Securities lowers Five9 stock price target on earnings guidance cut | ||
| 20:18 | Josh Gottheimer buys Applied Materials stock in managed account | ||
| 20:18 | Raymond James cuts Axon stock price target on federal delays | ||
| 20:18 | Raymond James reiterates Strong Buy on Columbia Banking stock | ||
| 20:18 | B.Riley cuts Koppers Holdings stock price target on weaker margins | ||
| 20:18 | Raymond James raises Wheaton Precious Metals price target on valuation | ||
| 20:18 | Jefferies raises Mettler-Toledo stock price target on solid growth | ||
| 20:18 | Truist holds Oklo stock rating at Hold on deployment progress | ||
| 20:06 | Truist raises Vericel stock price target on MACI growth momentum | ||
| 19:42 | Raymond James cuts Delek US stock price target on valuation review | ||
| 19:30 | Mizuho reiterates Sunrun stock rating on battery attach rate outlook | ||
| 19:30 | Truist raises EOG Resources stock price target to $166 on execution | ||
| 19:18 | Jefferies raises Inovio stock price target on regulatory win | ||
| 18:42 | Spectral Medical closes $14 million convertible notes offering | ||
| 18:42 | Jefferies cuts Targa Resources stock price target on margin concerns | ||
| 18:18 | Immunocore reports phase 1 data for uveal melanoma combination | ||
| 18:18 | Northland cuts Terawulf stock price target to $22.50 on market pricing | ||
| 18:06 | Susquehanna raises Wynn Resorts stock price target on project outlook | ||
| 18:06 | Canaccord cuts Kratos Defense stock price target on valuation | ||
| 17:30 | Freedom Broker raises Allison Transmission stock price target on strong Q3 results | ||
| 17:30 | Freedom Broker cuts MNTN stock price target on weak results | ||
| 17:30 | Freedom Broker cuts Intrepid Potash stock price target on weak Q3 | ||
| 17:18 | Evaxion presents phase 2 cancer vaccine biomarker data at SITC | ||
| 17:18 | Freedom Broker cuts Coinbase stock price target to $175 on weak Q4 setup | ||
| 17:18 | Wedbush raises IMAX stock price target to $62 on box office growth |